Optimizing PCI Outcomes After ACS: Anti-Inflammatory Therapies - unCLEAR SYNERGies?
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Teleflex; Penumbra; Asahi; Abiomed; Shockwave Medical</li><li>Grant Support/Research Contract - Boston Scientific Corporation</li></ul>